Abbott | ABT - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 10.46B 1.15B 2026-06
Agilent USD 1.43B 2M 2026-06
AtriCure USD 143.94M 3.22M 2026-06
Baxter International USD 2.68B 3.36B 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bio-Rad Laboratories USD 7.17B 322.6M 2026-06
Boston Scientific USD 4.2B 49M 2026-06
Cooper Companies USD 1.11B 301.2M 2026-03
Danaher USD 52.58B 368M 2026-06
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
Globus Medical USD 835.58M 239.73M 2026-06
Insulet USD 672M 32.3M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 1.91B 3.6M 2026-06
J&J USD 17.83B 388M 2026-06
Medtronic USD 7.72B 436M 2026-03
Merit Medical Systems USD 358.44M 20.72M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Smith & Nephew USD 2.59B 71M 2026-06
Solventum Corp USD 4.8B 169M 2026-06
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Terumo JPY 222.33B 46.54B 2026-06
Thermo Fisher Scientific USD 9.81B 716M 2026-06
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06